MRK Competitors & Alternatives
Compare Merck & Company Inc with similar stocks in the same industry
Drug Manufacturers - General
MRK
Main Stock$124.03
Tradestie Score
59
Market Cap
$225.13B
P/E Ratio
34.8
Revenue Growth
0.0%
Analyst Upside
+6.7%
Top Competitors
18 stocks in Drug Manufacturers - General| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
JNJ
Johnson & Johnson
|
$257.77
|
$448.07B | 29.8 | 58 | Compare |
|
ABBV
ABBVIE INC.
|
$248.00
|
$431.71B | 122.2 | 59 | Compare |
|
PG
Procter & Gamble Company
|
$148.37
|
$358.52B | 21.5 | 58 | Compare |
|
NVO
Novo-Nordisk A/S
|
$49.28
|
$262.92B | 11.9 | 64 | Compare |
|
AZN
AstraZeneca PLC
|
$169.47
|
$261.56B | 25.8 | 51 | Compare |
|
NVS
Novartis AG
|
$153.37
|
$254.99B | 22.1 | 49 | Compare |
|
VZ
Verizon Communications
|
$42.68
|
$184.80B | 10.3 | 58 | Compare |
|
AMGN
Amgen Inc
|
$360.45
|
$160.70B | 25.3 | 56 | Compare |
|
PFE
Pfizer Inc.
|
$24.48
|
$154.70B | 18.5 | 56 | Compare |
|
GILD
Gilead Sciences Inc
|
$131.40
|
$137.92B | 17.7 | 64 | Compare |
More MRK Analysis
Data updated: Jul 13, 2026 | Industry: Drug Manufacturers - General (SIC 2834)
18 stocks in this industry